PA8459501A1 - Formulaciones parasiticidas - Google Patents

Formulaciones parasiticidas

Info

Publication number
PA8459501A1
PA8459501A1 PA19988459501A PA8459501A PA8459501A1 PA 8459501 A1 PA8459501 A1 PA 8459501A1 PA 19988459501 A PA19988459501 A PA 19988459501A PA 8459501 A PA8459501 A PA 8459501A PA 8459501 A1 PA8459501 A1 PA 8459501A1
Authority
PA
Panama
Prior art keywords
parasiticide formulations
parasiticide
formulations
parasitical
administer
Prior art date
Application number
PA19988459501A
Other languages
English (en)
Inventor
Hiep Huatan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PA8459501A1 publication Critical patent/PA8459501A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION APORTA UN IMPLANTE SOLIDO QUE COMPRENDE AL MENOS UN COMPUESTO PARASITICIDA QUE TIENE UNA BAJA SOLUBILIDAD ACUOSA Y EXCIPIENTES DE COMPRESION ENTRE LOS QUE SE INCLUYE UN AGENTE DE RELLENO. LOS IMPLANTES DE ACUERDO CON LA INVENCION SON COMODOS DE ADMINISTRAR Y PROPORCIONAN UNA PROTECCION PROLONGADA FRENTE A PARASITOS.
PA19988459501A 1997-09-23 1998-09-17 Formulaciones parasiticidas PA8459501A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
PA8459501A1 true PA8459501A1 (es) 2000-05-24

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988459501A PA8459501A1 (es) 1997-09-23 1998-09-17 Formulaciones parasiticidas

Country Status (13)

Country Link
EP (1) EP1014970A1 (es)
JP (1) JP2001517622A (es)
AP (1) AP9801350A0 (es)
AR (1) AR013509A1 (es)
AU (1) AU9742298A (es)
BR (1) BR9812385A (es)
CA (1) CA2304283A1 (es)
GT (1) GT199800149A (es)
MA (1) MA24655A1 (es)
PA (1) PA8459501A1 (es)
PE (1) PE117199A1 (es)
TN (1) TNSN98175A1 (es)
WO (1) WO1999015166A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
WO2018226512A1 (en) * 2017-06-06 2018-12-13 Merck Sharp & Dohme Corp. Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
EP1014970A1 (en) 2000-07-05
AP9801350A0 (en) 2000-03-17
PE117199A1 (es) 1999-11-20
AU9742298A (en) 1999-04-12
JP2001517622A (ja) 2001-10-09
WO1999015166A1 (en) 1999-04-01
GT199800149A (es) 2000-03-15
TNSN98175A1 (fr) 2005-03-15
CA2304283A1 (en) 1999-04-01
MA24655A1 (fr) 1999-04-01
AR013509A1 (es) 2000-12-27
BR9812385A (pt) 2000-09-12

Similar Documents

Publication Publication Date Title
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
PT1140018E (pt) Suspensoes de poliol/oleo para a libertacao sustentada de proteinas
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
CR7140A (es) Antranilamidas con una cadena colateral de un heteroarylsulfonil, metodos para la produccion de los mismos, su uso como medicamento o agente diagnostico y preparaciones farmaceuticas contenidas en dichos compuestos
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
PA8459501A1 (es) Formulaciones parasiticidas
GT199800101A (es) Composicion farmaceutica solida que contiene un derivado de benzofurano.
ES2195189T3 (es) Benzonaftiridinas como agentes terapeuticos bronquiales.
CO4700420A1 (es) Formulacion transdermica
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
CU23113A3 (es) Represion de artropodos en animales
ES2171669T3 (es) Composicion farmaceutica que contiene hidrocloruro de tiagabina y su procedimiento de preparacion.
AR046402A1 (es) Combinacion de principio activo que comprende un compuesto 2,5-dihidrobencenosulfonico y un modulador de los canales de potasio
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ITMI20031714A1 (it) Formazioni ad azione antitumorale.
CO4750591A1 (es) Procedimiento de lucha contra los insectos
AR022294A1 (es) Combinaciones de productos activos fungicidas.
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
ES2191426T3 (es) Composiciones estables que comprenden levosimendano y acido alginico.
ATE273687T1 (de) Mundpflegezusammensetzung
ES2161913T3 (es) Complejos cationicos trinucleares de platino que tienen una actividad antitumoral y composiciones farmaceuticas que los contienen.
CO4940379A1 (es) Composiciones antimicrobianas para dejarlas sobre la piel que contienen antimicrobiano
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.